SCINAI IMMUNOTHERAPEUTICS LTD. Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest
SCINAI IMMUNOTHERAPEUTICS LTD. (SCNI) reported Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest of -$3.52 million for the 3-month period ending 2023-03-31, per its 10-Q filed 2023-05-15.
Discontinued › Shareholders' Equity
us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest · last filed 2023-05-15
- SCINAI IMMUNOTHERAPEUTICS LTD. net income (loss), including portion attributable to nonredeemable noncontrolling interest for the quarter ending 2023-03-31 was -$3.52M.
- SCINAI IMMUNOTHERAPEUTICS LTD. net income (loss), including portion attributable to nonredeemable noncontrolling interest for the quarter ending 2022-03-31 was -$2.48M.
| Period end | Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest 3 month |
|---|---|
| 2023-03-31 | -$3.52M 10-Q · filed 2023-05-15 |
| 2022-03-31 | -$2.48M 10-Q · filed 2023-05-15 |